18 results with keyword: 'factors predictive relapse leukemia children allogeneic hematopoietic transplantation'
In this retrospective analysis of pediatric patients with acute leukemias and myelodysplastic syndrome who un- derwent an allogeneic HCT, we sought to identify risk factors
N/A
Extramedullary relapse in acute leukemia following allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcomes.. Biol Blood
N/A
Bone marrow vs extramedullary relapse of acute leukemia after allogeneic hematopoietic cell transplantation: risk factors and clinical course.. Bone
N/A
To evaluate the efficacy of second allogeneic hematopoietic stem cell transplantation (HSCT) for relapse after initial allogeneic transplant in childhood leukemia, we
N/A
Background: After allogeneic hematopoietic stem cell transplantation (allo-HSCT), acute leukemia relapse is common, and asymmetric bone marrow recurrence hasn’t been
N/A
Allogeneic hematopoietic stem cell transplantation for patients with high risk acute lymphoblastic leukemia: favorable impact of chronic graft-versus-host disease on survival
N/A
Minimal residual disease prior to allogeneic hematopoietic cell transplantation has been associated with increased risk of relapse and death in patients with acute myeloid
N/A
Recently, Fang and Li [] considered equation (.) with q = , when the diffusion term was replaced by a doubly degenerate operator in the whole dimensional space, and they
N/A
We examined the incidence, risk factors, and out- come of CNS relapse after allogeneic HSCT in adult patients with acute myelogenous leukemia (AML), ALL, and chronic
N/A
tion after allogeneic hematopoietic stem cell transplantation is associated with a reduced risk of relapse in patients with acute myeloid leukemia who survived to day 100
N/A
Keywords: myelodysplastic syndrome, acute myeloid leukemia, Decitabine, transplantation conditioning, graft versus host disease, allogeneic hematopoietic stem cell
N/A
Relapse after allogeneic hematopoietic stem cell transplantation (HSCT) is a major concern in myelodysplastic syndromes (MDS), but the role of Wilms tumor gene 1 (WT1) as a
N/A
Allogeneic hematopoietic cell transplantation (allo-HCT) is an important and widely used treatment for patients with hematological malignancies, including Acute Myeloid Leukemia
N/A
The role of mixed T lymphocyte donor chimerism in predicting AML relapse after transplantation has been controversial, although no previous studies have strati fi ed patients based
N/A
Outcomes of Allogeneic Hematopoietic Cell Transplantation in Children (<18y) and Young adults (18–29y) with Chronic Myeloid Leukemia: A CIBMTR Cohort Analysis.. Sonali Chaudhury
N/A
In this review, we mainly focus on addressing the impact of graft-versus-host disease on relapse and the prophylaxis and treatment of acute lymphoblastic leukemia relapse
N/A
AHSCT: Allogeneic hematopoietic stem cell transplantation; ALL: Acute lymphoid leukemia; AML: Acute myeloid leukemia; BM: Bone marrow; CpGs: Cytosines adjacent to guanines;
N/A
at 674 (stating that Turfah was unlawfully admitted because he entered the United States twenty-four days too early), with Injeti v. 2013) (stating that Injeti was not
N/A